New diabetes clinical trial: A Randomized, Active-controlled, Parallel, Open-label, Multicenter, Phase 4 Study to Compare the Efficacy and Safety of Pregabalin Sustained Release Tablet and Pregabalin Immediate Release Capsule in Type II Diabetic Patients With Peripheral Neuropathic Pain

Published on: November 22, 2022 at 11:00AM
Conditions:   Neuropathic Pain;   Diabetes Mellitus, Type 2
Interventions:   Drug: pregabalin sustained release tablet;   Drug: pregabalin immediate release capsule
Sponsor:   Yuhan Corporation
Active, not recruiting
https://ift.tt/XfmOBsJ